Patent · US Active

Method of conferring a protective immune response to Norovirus

US9821049B2 · kind B2 · utility

10Cited by
22References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2013
Grant dateNov 21, 2017
Priority date
Expiry dateApr 2, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/16034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.